Development of Security Target for Router Based on ENISA Common Criteria Framework

Authors: Chen, Jiann-Liang, Hsu, Jian-Chang, Ahmadi, Candra, Atmaja, Bagus Tri, Lin, Chia-Chi, Wang, Siao-He, Lin, Shu-Yu

Source: 2023 25th International Conference on Advanced Communication Technology (ICACT) Advanced Communication Technology (ICACT), 2023 25th International Conference on. :117-121 Feb, 2023

Relation: 2023 25th International Conference on Advanced Communication Technology (ICACT)

Acrylamide, an air pollutant, enhances allergen-induced eosinophilic lung inflammation via group 2 innate lymphoid cells

Authors: Su, Hsiang-Han, Cheng, Chih-Mei, Yang, Yung-Ning, Chang, Yu-Wei, Li, Chia-Yang, Wu, Shin-Ting, Lin, Chia-Chi, Wu, Hsin-En, Suen, Jau-Ling

Source: In Mucosal Immunology February 2024 17(1):13-24

Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Authors: Wu, Chiao-En, Liao, Yi-Hua, Wu, Cheng-Lin, Yen, Ruoh-Fang, Lin, Chia-Chi, Yang, Muh-Hwa, Yen, Chueh-Chuan, Su, Wu-Chou, Yen, Chia-Jui, Chang, Yi-Fang, Wu, Ming-Fang, Yang, Youngsen, Lin, Chen-Yuan, Yang, Wen-Chi, Wang, Hui-Ching, Li, Cheng-Yuan, Ho, Yin-Yu, Chang, Yao-Yu, Wu, Chieh-Shan, Hsu, Hsiu-Cheng, Chen, Kuang-Hua, Huang, Yenlin, Chen, Chih-Jung, Chuang, Pei-Ju, Lai, Yung-Chi, Huang, Yu-Yi, Tseng, Neng-Chuan, Huang, Yi-Ting, Chu, Chia-Yu, Wen-Cheng Chang, John

Source: In Journal of the Formosan Medical Association January 2024 123(1):7-15

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer

Authors: Guo, Jhe‐Cyuan, Hsu, Chia‐Lang, Hsieh, Min‐Shu, Lin, Chia‐Chi, Huang, Ta‐Chen, Kuo, Hung‐Yang, Shao, Yu‐Yun, Hsu, Chih‐Hung

Source: Thoracic cancer. 14(22):2216-2221

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190002076.0x000001&indx=1&recIds=ETOCvdc_100190002076.0x000001

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study

Authors: Oh, Do‐Youn, Algazi, Alain, Capdevila, Jaume, Longo, Federico, Miller, Wilson, Chun Bing, Jerry Tan, Bonilla, Carlos Eduardo, Chung, Hyun Cheol, Guren, Tormod K., Lin, Chia‐Chi, Motola‐Kuba, Daniel, Shah, Manisha, Hadoux, Julien, Yao, Lili, Jin, Fan, Norwood, Kevin, Lebellec, Loïc

Source: Cancer. 129(8):1195-1204

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184355085.0x000001&indx=1&recIds=ETOCvdc_100184355085.0x000001

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC

Authors: Zhou, Qing, Soo, Ross A., Chang, Gee-Chen, Chiu, Chao-Hua, Hayashi, Hidetoshi, Kim, Sang-We, Teraoka, Shunsuke, Goto, Yasushi, Zhou, Jianying, Ho-Fun Lee, Victor, Kim, Dong-Wan, Han, Baohui, Chung Man Ho, James, Lin, Chia-Chi, Lu, Shun, Polli, Anna, Calella, Anna Maria, Martini, Jean-François, Wong, Chew Hooi, Mok, Tony, Kim, Hye Ryun, Wu, Yi-Long

Source: In JTO Clinical and Research Reports May 2023 4(5)

Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial

Authors: Soo, Ross A., Huat Tan, Eng, Hayashi, Hidetoshi, Seto, Takashi, Lin, Chia-Chi, Ignatius Ou, Sai-Hong, Kim, Dong-Wan, Liu, Geoffrey, Abbattista, Antonello, Martini, Jean-François, Hooi Wong, Chew, Toffalorio, Francesca, Solomon, Benjamin J.

Source: Lung cancer. 169:67-76

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191804015.0x000001&indx=1&recIds=ETOCvdc_100191804015.0x000001

Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial

Authors: Brose, Marcia S., Robinson, Bruce G., Sherman, Steven I., Jarzab, Barbara, Lin, Chia‐Chi, Vaisman, Fernanda, Hoff, Ana O., Hitre, Erika, Bowles, Daniel W., Sen, Suvajit, Oliver, Jennifer W., Banerjee, Kamalika, Keam, Bhumsuk, Capdevila, Jaume

Source: Cancer. 128(24):4203-4212

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184355072.0x000001&indx=1&recIds=ETOCvdc_100184355072.0x000001

Immunotherapy in anaplastic thyroid cancer: Case series

Authors: Shih, Shyang-Rong, Chen, Kuan-Hua, Lin, Kuan-Yu, Yang, Pan-Chyr, Chen, Kuen-Yuan, Wang, Chun-Wei, Chen, Chun-Nan, Lin, Chih-Feng, Lin, Chia-Chi

Source: Journal of the Formosan Medical Association. 121(6):1167-1173

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165601055.0x000001&indx=1&recIds=ETOCvdc_100165601055.0x000001

Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens

Authors: Ma, Wei‐Li, Lin, Chia‐Chi, Hsu, Feng‐Ming, Lee, Jang‐Ming, Chen, Jin‐Shing, Huang, Yen‐Lin, Chang, Yih‐Leong, Chang, Chin‐Hao, Yang, James Chih‐Hsin

Source: Cancer medicine. 11(18):3445-3456

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100162714513.0x000001&indx=1&recIds=ETOCvdc_100162714513.0x000001

Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)

Authors: Brose, Marcia S., Smit, Johannes W.A., Lin, Chia-Chi, Tori, Masayuki, Bowles, Daniel W., Worden, Francis, Shen, Daniel Hueng-Yuan, Huang, Shih-Ming, Tsai, Hui-Jen, Alevizaki, Maria, Peeters, Robin P., Takahashi, Shunji, Rumyantsev, Pavel, Guan, Rongjin, Babajanyan, Svetlana, Ozgurdal, Kirhan, Sugitani, Iwao, Pitoia, Fabian, Lamartina, Livia

Source: Thyroid. 32(9):1059-1068

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100161125454.0x000001&indx=1&recIds=ETOCvdc_100161125454.0x000001

First-in-human phase 1/2 study (MYCHELANGELO I) of first-in-class epigenomic controller OTX-2002 targeting MYC oncogene in patients with hepatocellular carcinoma (HCC) and other solid tumors.

Authors: Mizrahi, Jonathan, Senapedis, William, O'Donnell, Charles, Hodgson, J. Graeme, Newman, Joseph V., Siecinski, Stephen, Lin, Chia-Chi

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p606-606, 132p

A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib.

Authors: Desai, Jayesh, Wagner, Andrew J., Carrasco Garcia, Irene, Cesari, Marilena, Gordon, Michael, Lin, Chia‐Chi, Papai, Zsuzsanna, Ryan, Christopher W., Tap, William D., Trent, Jonathan C., Gelderblom, Hans, Grimison, Peter, López Pousa, Antonio, Van Tine, Brian A., Rubinacci, Maria, Dai, Dong, Rajper, Abdul Waheed, Tecson, Kristen, Wooddell, Margaret, Stacchiotti, Silvia

Source: Cancer (0008543X); Jan2025, Vol. 131 Issue 1, p1-14, 14p

Subject Terms: GIANT cell tumors, VISUAL analog scale, PHYSICAL mobility, SURVIVAL rate, CANCER invasiveness

Digital Storybook of Young Product Innovators: An E-Learning Approach to Support Creative Thinking for Elementary Science

Authors: Jih, Hueyching Janice, Huang, Tzu-Ying, Lin, Chia-Chi

Source: 2011 International Conference on Internet Technology and Applications Internet Technology and Applications (iTAP), 2011 International Conference on. :1-4 Aug, 2011

Relation: 2011 International Conference on Internet Technology and Applications (iTAP)

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

Authors: Subbiah, Vivek ^*, Hu, Mimi I, Wirth, Lori J, Schuler, Martin, Mansfield, Aaron S, Curigliano, Giuseppe, Brose, Marcia S, Zhu, Viola W, Leboulleux, Sophie, Bowles, Daniel W, Baik, Christina S, Adkins, Douglas, Keam, Bhumsuk, Matos, Ignacio, Garralda, Elena, Gainor, Justin F, Lopes, Gilberto, Lin, Chia-Chi, Godbert, Yann, Sarker, Debashis, Miller, Stephen G, Clifford, Corinne, Zhang, Hui, Turner, Christopher D, Taylor, Matthew H

Source: In The Lancet Diabetes & Endocrinology August 2021 9(8):491-501

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial

Authors: Brose, Marcia S ^{a, *}, Robinson, Bruce ^b, Sherman, Steven I ^c, Krajewska, Jolanta ^d, Lin, Chia-Chi ^e, Vaisman, Fernanda ^f, Hoff, Ana O ^g, Hitre, Erika ^h, Bowles, Daniel W ⁱ, Hernando, Jorge ^j, Faoro, Leonardo ^k, Banerjee, Kamalika ^k, Oliver, Jennifer W ^k, Keam, Bhumsuk ^l, Capdevila, Jaume ^j

Source: In The Lancet Oncology August 2021 22(8):1126-1138

Electronic device

Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC

Authors: Liao, Bin-Chi, Hsu, Wei-Hsun, Lee, Jih-Hsiang, Yang, Ching-Yao, Tsai, Tzu-Hsiu, Liao, Wei-Yu, Ho, Chao-Chi, Lin, Chia-Chi, Shih, Jin-Yuan, Yu, Chong-Jen, Soo, Ross A., Yang, James Chih-Hsin

Source: In JTO Clinical and Research Reports January 2021 2(1)

Endoscopic ultrasound ablation in a patient with multiple metastatic pancreatic tumors from adrenocorticotropic hormone‐producing thymic neuroendocrine neoplasm

Authors: Chang, Ling‐Kai, Chen, Kuan‐Chih, Cheng, Mei‐Fang, Lin, Chia‐Chi, Wang, Hsiu‐Po, Sung, Chia‐Tung, Chen, Jou‐Ho, Yen, Ruoh‐Fang, Hsu, Chia‐Lin, Shih, Shyang‐Rong

Source: Digestive endoscopy. 33(3):458-463

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100140008211.0x000001&indx=1&recIds=ETOCvdc_100140008211.0x000001

Phase I Dose‐Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors

Authors: Shiah, Her‐Shyong, Chiang, Nai‐Jung, Lin, Chia‐Chi, Yen, Chia‐Jui, Tsai, Hui‐Jen, Wu, Shang‐Yin, Su, Wu‐Chou, Chang, Kwang‐Yu, Wang, Ching‐Chiung, Chang, Jang‐Yang, Chen, Li‐Tzong

Source: Oncologist. 26(4):e567-e579

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120199685.0x000001&indx=1&recIds=ETOCvdc_100120199685.0x000001